access to medicines
Oxfam has hailed the Indian Supreme Court’s ruling against a patent protection petition filed by multinational pharmaceutical company Novartis as a huge victory for public health.
Pharmaceutical giant Novartis is back in court this week, in a renewed attempt to block India’s right to produce affordable ‘generic’ versions of the company’s branded medicines.
As the International AIDS Conference wrapped up today, international aid agency Oxfam praised the advocates and the scientists who have ignited momentum to shift from “fighting AIDS” to “ending AIDS,” and urged governments and the pharmaceutical industry to make this vision a reality.
Despite commitment to end AIDS, the US government is introducing stronger intellectual property rules through trade agreements and bilateral pressure that will undermine the fight against AIDS by devastating the ability of developing countries to access affordable anti-retroviral medicines.
Oxfam strongly welcomes the European Parliament’s vote against the Anti-Counterfeiting Trade Agreement (ACTA) by a majority of 478 votes out of 682. ACTA would have posed a serious
India is known as the pharmacy of the world but 65% of Indians have no access to essential medicines. This video explains how the State of Rajasthan in India is tackling the problem by promoting generic medicines and providing these free of charge in the public sector.
Poor-quality, or “substandard”, medicines threaten patients and public health in developing countries.